Literature DB >> 18301878

Aprotinin and microvascular thrombosis in cardiac surgery.

Marco Ranucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18301878     DOI： 10.1007/s00134-008-1043-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  The risk associated with aprotinin in cardiac surgery.

Authors:  Dennis T Mangano; Iulia C Tudor; Cynthia Dietzel
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

2.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.

Authors:  M Levi; M E Cromheecke; E de Jonge; M H Prins; B J de Mol; E Briët; H R Büller
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

3.  Effect of aprotinin on need for blood transfusion after repeat open-heart surgery.

Authors:  D Royston; B P Bidstrup; K M Taylor; R N Sapsford
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

4.  Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.

Authors:  Dennis T Mangano; Yinghui Miao; Alain Vuylsteke; Iulia C Tudor; Rajiv Juneja; Daniela Filipescu; Andreas Hoeft; Manuel L Fontes; Zak Hillel; Elisabeth Ott; Tatiana Titov; Cynthia Dietzel; Jack Levin
Journal:  JAMA       Date:  2007-02-07       Impact factor: 56.272

5.  Elevated pulmonary dead space and coagulation abnormalities suggest lung microvascular thrombosis in patients undergoing cardiac surgery.

Authors:  Barry Dixon; Duncan J Campbell; John D Santamaria
Journal:  Intensive Care Med       Date:  2008-02-27       Impact factor: 17.440
  5 in total
  1 in total

Review 1.  Year in review in Intensive Care Medicine, 2008: II. Experimental, acute respiratory failure and ARDS, mechanical ventilation and endotracheal intubation.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2009-01-06       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.